Lung Metastases Clinical Trials

8 recruiting

Lung Metastases Trials at a Glance

10 actively recruiting trials for lung metastases are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Duarte, Fitzroy, and Houston. Lead sponsors running lung metastases studies include City of Hope Medical Center, European Institute of Oncology, and Centre Hospitalier Universitaire Vaudois.

Browse lung metastases trials by phase

Treatments under study

About Lung Metastases Clinical Trials

Looking for clinical trials for Lung Metastases? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lung Metastases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lung Metastases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 1

In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung

Colorectal Cancer MetastaticLung Metastases
University Health Network, Toronto10 enrolled1 locationNCT05611034
Recruiting
Phase 3

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Lung CancerLung Metastases
Vergent Bioscience, Inc.132 enrolled6 locationsNCT07499674
Recruiting
Phase 2

Phase II Trial of Lung Chemoemobolization

SarcomaColon CancerLung Non-Small Cell Carcinoma+4 more
City of Hope Medical Center30 enrolled2 locationsNCT05672108
Recruiting
Not Applicable

Oxford Pleural Embolisation Trial

Lung CancerLung Metastases
Oxford University Hospitals NHS Trust106 enrolled1 locationNCT06651658
Recruiting
Not Applicable

MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery

Primary Lung Cancer or Secondary Lung Metastases
University of Zurich11 enrolled1 locationNCT06815289
Recruiting

Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors

Lung MetastasesBone Metastases From Solid TumorsBone and Soft Tissue Tumors
Istituto Ortopedico Rizzoli125 enrolled1 locationNCT07112989
Recruiting

On-treatment Biomarkers in Metastatic Colorectal Cancer for Life

Metastatic Colorectal CancerChemotherapy EffectPeritoneal Metastases+2 more
Region Skane100 enrolled2 locationsNCT05755672
Recruiting

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

Breast CancerColorectal, CancerUrothelial Carcinoma+5 more
European Institute of Oncology265 enrolled1 locationNCT06321640
Recruiting

AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer

Lung CancerLung MetastasesIndeterminate Pulmonary Nodules+1 more
Royal Marsden NHS Foundation Trust1,000 enrolled2 locationsNCT05375591
Recruiting

Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung Cancer

Lung CancerRadiotherapyLung Metastases
Centre Hospitalier Universitaire Vaudois60 enrolled1 locationNCT04684186